By Peter A. McCullough, MD, MPH
If the original trials of Pfizer and Moderna COVID-19 vaccines delivered true results, we would have seen 90% percent reductions in the incidence of acute COVID-19. In fact we saw just the opposite—explosive increases in the risk for acute illness after vaccination both on an individual and population basis.
I asked pharmacist and philosophy researcher Dr. Raphael Lataster from the University of Sydney to join me and explain how vaccine efficacy became so distorted and grossly overestimated.
Raphael Lataster holds a PhD from the University of Sydney, and occasionally lectures there and at other institutions. His main academic research interests include misinformation, disinformation, and fake news, in Health and Politics.
Raphael has a Bachelor of Pharmacy, a Masters of Applied Finance, and several postgraduate research degrees in the Arts. Initially focussing his academic efforts around misinformation in Religion, he has shifted focus to misinformation in Politics and Health, particularly around COVID-19.
He currently runs Okay Then News, which highlights counter-narrative news pieces and journal articles.
Please subscribe to Courageous Discourse as a paying ($5 monthly) or founder member so we can continue to bring you the truth.
Peter A. McCullough, MD, MPH
President, McCullough Foundation
Dr. Lataster References
Research on COVID-19 vaccines in medical journals:
- Excess deaths in Europe correlate with the jabs. Article. OTN summary.
- Latest article on negative effectiveness in AJGP. Article. OTN summary.
- Articles with the BMJ’s Dr. Peter Doshi on exaggerated effectiveness & safety in JECP. OTN summary.
Other contributions:
- 1st win against NSW Health vaccine mandate. OTN summary. 2nd win. OTN summary.
- US Senate videos. OTN summary.
- Breaking news/FOI request on dodgy counting windows in NSW Health reports. OTN summary.
- Clear evidence that the major companies are owned by the same few ultra-wealthy people. OTN summary.
Threats to Validity Overturn Stated Results of COVID-19 Vaccine Trials